Tony Jeffries

Tony Jeffries

Partner, Chair of the Board

Comprehensive Corporate and Securities Experience

Tony has more than 25 years of experience representing clients in a broad range of corporate and securities matters including IPOs and other public offerings, corporate governance, M&A transactions, strategic alliances, venture financings, and other transactional matters.
Represents Innovative Technology and Life Sciences Companies

Tony represents innovative technology and life sciences clients in a variety of sectors.
Recognized as a Leading Corporate Attorney

Tony was named in the 2018-2023 editions of Chambers USA: America's Leading Lawyers for Business and the 2020-2024 editions of Chambers Global.
Thought Leadership

Tony has been quoted in numerous articles about IPOs and other corporate transactional mattters in business and legal industry media, including Dow Jones/The Wall Street Journal, The Silicon Valley Business Journal, Law360, The Recorder, and The Daily Journal.

Tony Jeffries is chair of Wilson Sonsini Goodrich & Rosati’s board of directors and a partner at the firm, where his practice focuses on corporate, securities, governance, and related matters for technology and life sciences companies.

With more than 25 years of experience practicing corporate and securities law, Tony has represented clients ranging from entrepreneurs to Fortune 500 companies on IPOs and other public offerings, corporate governance, mergers and acquisitions, strategic alliances, venture capital financings, the structuring of start-up companies, and other transactional matters.

Among the clients Tony represents are companies in a wide variety of technology and life sciences sectors. He also represents prominent venture capital firms and investment banks.

Tony is a member of the Board of Visitors at Duke University School of Law.

Experience

Among the clients Tony represents are companies in a wide variety of technology and life sciences sectors. He also represents prominent venture capital firms and investment banks.

Tony is a member of the Board of Visitors at Duke University School of Law.

Education

J.D., Duke University School of Law, 1992With High Honors
B.S., Finance, University of Colorado, Boulder, 1989Cum Laude

Honors

Named in the 2020-2024 editions of Chambers Global, where he is described as “very thoughtful, collaborative and results-oriented”
Named in the 2018-2023 editions of Chambers USA: America's Leading Lawyers for Business, where one source noted he is a “great partner who has got a really great practice,” while another stated he is “not only a supremely talented lawyer, but possesses great practical insights informed by extensive experience”

Admissions

State Bar of California
State Bar of Colorado

Credentials

Education

J.D., Duke University School of Law, 1992With High Honors
B.S., Finance, University of Colorado, Boulder, 1989Cum Laude

Honors

Named in the 2020-2024 editions of Chambers Global, where he is described as “very thoughtful, collaborative and results-oriented”
Named in the 2018-2023 editions of Chambers USA: America's Leading Lawyers for Business, where one source noted he is a “great partner who has got a really great practice,” while another stated he is “not only a supremely talented lawyer, but possesses great practical insights informed by extensive experience”

Admissions

State Bar of California
State Bar of Colorado

Select Recent IPOs

HashiCorp (2021)
Udemy (2021)
KnowBe4 (2021)
Impel NeuroPharma (2021 —Underwriters Counsel)
Edgewise Therapeutics (2021)
Seer (2020)
Kinnate Biopharma (2020)
ORIC Pharmaceuticals (2020)
IGM Biosciences (2019)
Peloton Therapeutics (2019—sold on eve of IPO)
Allakos (2018)
Dropbox (2018)
Okta (2017—Underwriters Counsel)
Denali Therapeutics (2017)

Select Public Clients

Block (Square)
Denali Therapeutics
Edgewise Therapeutics
Hawaiian Airlines
IGM Biosciences
Inspirato
Kinnate Biopharma
KnowBe4
Seer
Zymeworks

Select Private Clients

Druva
Enliven
onX
Plaid
Pinger

Clients

Select Recent IPOs

HashiCorp (2021)
Udemy (2021)
KnowBe4 (2021)
Impel NeuroPharma (2021 —Underwriters Counsel)
Edgewise Therapeutics (2021)
Seer (2020)
Kinnate Biopharma (2020)
ORIC Pharmaceuticals (2020)
IGM Biosciences (2019)
Peloton Therapeutics (2019—sold on eve of IPO)
Allakos (2018)
Dropbox (2018)
Okta (2017—Underwriters Counsel)
Denali Therapeutics (2017)

Select Public Clients

Block (Square)
Denali Therapeutics
Edgewise Therapeutics
Hawaiian Airlines
IGM Biosciences
Inspirato
Kinnate Biopharma
KnowBe4
Seer
Zymeworks

Select Private Clients

Druva
Enliven
onX
Plaid
Pinger

Select Publications

Tony has been interviewed and quoted in numerous business and legal trade media, including Dow Jones/The Wall Street Journal, The Silicon Valley Business Journal, Law360, The Recorder, and The Daily Journal.

Recent Speaking Engagements

Panelist, “Nasdaq IPO Bootcamp Webinar Series: Achieving Success as a New Public Company,” May 27, 2020
Panelist, "Forging ahead: What will shape IPOs in 2018?" Nasdaq Entrepreneurial Center, San Francisco, California, February 2018
Lecturer, "Funding a New Enterprise – IPOs, M&A And Other Exits," Stanford Continuing Studies Class, Stanford, California, January 2016
Moderator, "An Evening with the Experts: IPO Panel Discussion," National Investor Relations Institute, San Francisco, California, October 2014
Panelist, "Compensation Trends and Best Practices," Tech America Board Education Event, Portland, Oregon, November 2010 and November 2011
Lecturer, "Intellectual Property Issues in IPOs, M&A Transactions, and Other Strategic Transactions," Stanford Law School, Stanford, California, January 2011
Presenter, "Preparing for the IPO," Morgan Stanley's "Going Public 2010" Conference, Menlo Park, California, June 2010

Insights

Select Publications

Tony has been interviewed and quoted in numerous business and legal trade media, including Dow Jones/The Wall Street Journal, The Silicon Valley Business Journal, Law360, The Recorder, and The Daily Journal.

Recent Speaking Engagements

Panelist, “Nasdaq IPO Bootcamp Webinar Series: Achieving Success as a New Public Company,” May 27, 2020
Panelist, "Forging ahead: What will shape IPOs in 2018?" Nasdaq Entrepreneurial Center, San Francisco, California, February 2018
Lecturer, "Funding a New Enterprise – IPOs, M&A And Other Exits," Stanford Continuing Studies Class, Stanford, California, January 2016
Moderator, "An Evening with the Experts: IPO Panel Discussion," National Investor Relations Institute, San Francisco, California, October 2014
Panelist, "Compensation Trends and Best Practices," Tech America Board Education Event, Portland, Oregon, November 2010 and November 2011
Lecturer, "Intellectual Property Issues in IPOs, M&A Transactions, and Other Strategic Transactions," Stanford Law School, Stanford, California, January 2011
Presenter, "Preparing for the IPO," Morgan Stanley's "Going Public 2010" Conference, Menlo Park, California, June 2010

Recent Insights

News Articles

On October 18, 2024, Lawdragon published its fifth edition of its Leading Dealmakers in America guide. The 2025 guide recognizes “the eminents of M&A, the power players of private equity, the consiglieres of capital markets” and “the lawyers firms cherish for their swagger, can-do hustle, and ability to move the needle with clients and firms themselves.”

Learn More

Client Highlights

Wilson Sonsini is pleased to have represented Hawaiian Airlines in its recently completed acquisition by Alaska Airlines.

Learn More

View All

Recent Events

Affiliated Programs

Wilson Sonsini is proud to sponsor the Biocom California CEO Summit in the California Bay Area, the premier conference designed exclusively for CEOs in the life science industry.

Learn More

Speaking Engagements

Tony Jeffries will moderate the CEO Panel Discussion: Addressing the Challenging Financial Market. Panelists include Kristine Ball, CEO, Soteria Biotherapeutics; Emily Drabant Conley, CEO, Federation Bio; and Fred Schwarzer, CEO, IGM Biosciences.

Learn More